153 related articles for article (PubMed ID: 21450967)
1. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
Kvach EJ; Ferguson D; Riska PF; Landry ML
J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
Shin BM; Mun SJ; Yoo SJ; Kuak EY
J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
[TBL] [Abstract][Full Text] [Related]
5. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
[TBL] [Abstract][Full Text] [Related]
7. Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.
Culbreath K; Ager E; Nemeyer RJ; Kerr A; Gilligan PH
J Clin Microbiol; 2012 Sep; 50(9):3073-6. PubMed ID: 22718938
[TBL] [Abstract][Full Text] [Related]
8. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
10. Is repeat PCR needed for diagnosis of Clostridium difficile infection?
Luo RF; Banaei N
J Clin Microbiol; 2010 Oct; 48(10):3738-41. PubMed ID: 20686078
[TBL] [Abstract][Full Text] [Related]
11. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection.
Knetsch CW; Bakker D; de Boer RF; Sanders I; Hofs S; Kooistra-Smid AM; Corver J; Eastwood K; Wilcox MH; Kuijper EJ
J Clin Microbiol; 2011 Jan; 49(1):227-31. PubMed ID: 20980562
[TBL] [Abstract][Full Text] [Related]
12. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
Nistico JA; Hage JE; Schoch PE; Cunha BA
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903
[TBL] [Abstract][Full Text] [Related]
13. An unusual cause of false-positive results with the BD GeneOhm Cdiff assay.
Louie L; Wong H; Mubareka S; Simor AE
J Clin Microbiol; 2013 Apr; 51(4):1348-9. PubMed ID: 23345300
[No Abstract] [Full Text] [Related]
14. Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains?
Kozak K; Elagin V; Norén T; Unemo M
J Clin Microbiol; 2011 Jun; 49(6):2383; author reply 2383-4. PubMed ID: 21617002
[No Abstract] [Full Text] [Related]
15. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
Huang H; Weintraub A; Fang H; Nord CE
J Clin Microbiol; 2009 Nov; 47(11):3729-31. PubMed ID: 19741082
[TBL] [Abstract][Full Text] [Related]
16. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
Hirvonen JJ; Mentula S; Kaukoranta SS
J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
[TBL] [Abstract][Full Text] [Related]
20. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
Chang FC; Liu CP; Sun FJ; Lin CC
J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
